Double-valve libman-sacks endocarditis causing ventricular fibrillation cardiac arrest

Texas Heart Institute Journal

Volumn 38, Issue 3, 2011, Pages 295-297

  Tanawuttiwat, Tanyanan ^a   Dia, Muhyaldeen ^a   Hanif, Tabassum ^a   Mihailescu, Mihaela ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Disease progression; Endocarditis etiology; Heart diseases complications; Heart valve diseases complications immunology physiopathology; Lupus erythematosus; Systemic complications physiopathology; Treatment outcome

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYCHLOROQUINE; STEROID; WARFARIN;

ADULT; AORTA VALVE; ARM WEAKNESS; ARTICLE; ASCENDING AORTA; BRAIN EMBOLISM; BRAIN INFARCTION; CASE REPORT; CHORDA TENDINEA; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CYANOSIS; ELECTROCARDIOGRAM; EMERGENCY SURGERY; ENDOCARDITIS; FEMALE; FIBRIN CLOT; GRANULATION TISSUE; HEART ARREST; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HUMAN; LIBMAN SACKS ENDOCARDITIS; MITRAL VALVE; MITRAL VALVE REGURGITATION; POSTOPERATIVE PERIOD; RESUSCITATION; SINUS TACHYCARDIA; SYNCOPE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

AORTIC VALVE; BIOPSY; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY RESUSCITATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; HEART ARREST; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; YOUNG ADULT;

EID: 79959924070     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007;120(7):636-42.
2. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990;82(2):369-75.
3. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335(8705):1541-4.
4. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus. A correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
5. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975;58(2): 243-64.
6. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93(8):1579-87.
7. Georghiou GP, Shapira Y, Drozd T, Erez E, Raanani E, Vidne BA, Sahar G. Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. J Heart Valve Dis 2003;12(6):797-801.
8. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update.Clin Rev Allergy Immunol 2009;36(2-3):126-30.